Horizon Kinetics Medical ETF Rating $37.17 -0.38 (-1.01%) As of 07/2/2026 01:19 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.67Holdings in MEDX have an aggregate rating of Moderate Buy based on 393 analyst ratings issued in the past year covering 22 companies (78.7% of the portfolio).MEDX Aggregate Price Target$37.17High Prediction$37.17Average Prediction$37.17Low Prediction$37.17Holdings in MEDX have an aggregate price target of $37.17 and a range of $37.17 to $37.17 covering 22 companies (78.7% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 MEDX Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.96%LLYEli Lilly and Company$1,208.37-0.5%4.2855 of 5 stars2.87$1,235.07 2.2%30Trending NewsAnalyst UpgradeAnalyst Revision8.63%ABBVAbbVie$260.88-0.1%4.0114 of 5 stars2.88$253.81 -2.7%25Analyst DowngradeAnalyst RevisionGap Down5.56%ALKSAlkermes$54.581.7591 of 5 stars2.72$49.63 -9.1%18Analyst ForecastInsider TradeGap Down5.54%JNJJohnson & Johnson$262.52-0.2%4.2566 of 5 stars2.74$256.70 -2.2%27Trending NewsGap Down4.57%IONSIonis Pharmaceuticals$81.803.329 of 5 stars2.90$102.90 25.8%21Insider TradeGap Down4.41%BMYBristol Myers Squibb$58.05-0.1%4.5937 of 5 stars2.37$61.31 5.6%19Options VolumeAnalyst RevisionGap Down3.97%AMGNAmgen$374.153.9256 of 5 stars2.43$355.50 -5.0%30Positive NewsAnalyst ForecastGap Down3.88%MRKMerck & Co., Inc.$129.34-0.2%4.4681 of 5 stars2.70$131.83 1.9%20Positive NewsAnalyst ForecastAnalyst RevisionGap Down3.49%ALNYAlnylam Pharmaceuticals$312.784.2306 of 5 stars2.85$461.39 47.5%26Analyst RevisionGap Down2.98%BIIBBiogen$216.123.4703 of 5 stars2.52$217.41 0.6%312.98%PFEPfizer$24.29-0.1%4.5415 of 5 stars2.25$28.82 18.7%20Analyst DowngradeAnalyst Revision2.75%GSKGSK$53.69+0.1%3.0528 of 5 stars2.00$53.00 -1.3%10Positive NewsDividend Cut2.71%CRSPCRISPR Therapeutics$60.082.1276 of 5 stars2.58$67.78 12.8%19News CoverageAnalyst DowngradeOptions Volume2.15%REGNRegeneron Pharmaceuticals$654.274.8614 of 5 stars2.73$792.65 21.2%26Positive NewsAnalyst DowngradeGap Down1.56%BEAMBeam Therapeutics$34.791.9783 of 5 stars2.71$46.83 34.6%14Gap Down1.07%NTLAIntellia Therapeutics$17.562.3425 of 5 stars2.35$20.46 16.5%231.01%GALTGalectin Therapeutics$4.511.586 of 5 stars2.00$11.00 143.9%2Insider TradeGap Down0.82%SDZNYSandoz Group$89.711.5217 of 5 stars3.504News Coverage0.78%REPLReplimune Group$11.581.6156 of 5 stars2.00$8.13 -29.8%10Earnings ReportAnalyst ForecastGap Down0.73%VNDAVanda Pharmaceuticals$6.212.655 of 5 stars2.50$14.30 130.3%8News CoveragePositive NewsGap Down0.62%HLNHaleon$9.81-0.2%2.8436 of 5 stars2.679Analyst Forecast0.54%LTRNLantern Pharma$3.970.7221 of 5 stars1.001Gap Up This page (NASDAQ:MEDX) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
